Myocardial Injury Completed Phase 4 Trials for Sevoflurane (DB01236)

IndicationStatusPhase
DBCOND0029874 (Myocardial Injury)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00569816Continuous Versus Repetitive Sevoflurane Administration for PreconditioningTreatment